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Figure S1. NE does not affect tumor cell proliferation. Related to Figure 5. 
HEp3 (A) and PC3-hi/diss (B) tumor cells were treated with 100 nM NE for 2 or 6 hr, washed 
and plated at 5x104 cells per well in triplicate. After 48-hr incubation, the cells were detached 
and counted. Two independent experiments were performed for each tumor cell type. Data are 




































Figure S2. Inhibition of NE-mediated cleavage of CD44 by Sivelestat. Related to Figure 5. 
PC3-hi/diss cells were left untreated or treated with 50 nM NE alone or pre-mixed with 
Sivelestat at the indicated increasing concentrations (0.3 to 10 mM). After 8-hr-incubation, the 
cell in each treatment culture (detached and still attached) were washed and lysed. Equal 
amounts of cell lysates (40 g/lane) were probed under non-reducing conditions for the C-
terminus and N-terminus CD44 with the corresponding terminus-specific antibodies. The blots 
indicate that CD44 is efficiently cleaved as evidenced by the diminishment of the extracellular 
N-terminal portion of 75 kDa full length CD44 and appearance of C-terminal cleavage 
fragments. At 3-10-M range, Sivelestat efficiently blocked NE-mediated cleavage of CD44. 












































































Figure S3. NE does not induce activation of p38 and Erk1/2 MAPKs. Related to Figure 5. 
(A) HEp3 cells were serum starved and then treated with 100 nM NE for 20 min or 1 or 10 
mg/ml LPS for 6 hours as a positive control for activation of p38 (A) or Erk1/2 (B). Equal 
amount of protein in cell lysates were loaded per lane (40 g) of a gel run under reduced 
conditions. The phosphorylation of p38 and Erk1/2 was analyzed with the corresponding specific 
antibodies against phosphorylated p38 and p42/p44. Equal load was confirmed by probing blots 



























































































Figure S4. NE is required for efficient lung retention of vascular-arrested PC3-hi/diss cells.  
Related to Figure 6. 
(A) PC3-hi/diss cells were stained with red-fluorescence dye (Abcam) and inoculated into the 
tail vein of C57BL/6 mice, WT or NE-KO (1x106 cells per mouse). The numbers of tumor cells 
arrested in the lung vasculature and cells retained in the lung tissue were measured within 20 min 
and 14 hr after cell inoculations, respectively, with human-specific Alu-qPCR. Two independent 
experiments were performed involving a total of 10 to 12 mice per variable. ***, P<0.001, two-
tailed Student’s t-test. Data are presented as mean ± SEM. 
(B) Red-fluorescent PC3-hi/diss tumor cells were imaged in the lungs in an immunofluorescence 
microscope equipped with a digital video camera. Original magnification, 200x. Bar, 100 m. 
(C) Retention indices were quantified for each mouse as the fraction (%) of PC3-hi/diss cells 
retained in the lung compared to the number of inoculated cells initially arrested in the lung 










































































































































Figure S5. Lack of inhibitory effects of Sivelestat on lung retention. Related to Figure 6. 
HEp3 cells were inoculated into the tail vein of immunodeficient SCID mice at 1x106 cells per 
mouse. The mice were treated with a total of 1 to 3.5 mg Sivelestat per mouse, administered by 
i.p. or i.v. routes, 2-3 times within the 12 hr period before lung harvest. Control mice received 
equal volume of vehicle (4% DMSO in PBS). The number of HEp3 cells retained in the lung 
after 12 hr following cell inoculation was measured with human-specific Alu-qPCR. Four 
independent experiments involving a total of 30 and 31 mice per vehicle control and Sivelestat 
were performed. The individual mouse data from these experiments were pooled since there 





































Chemicals and reagents 
Purified NE was purchased from Athens Research & Technology, Inc. (Athens, Georgia). 
Natural inhibitor 1PI and protease and phosphatase inhibitor cocktails were from Sigma (St 
Louis, MO). Synthetic NE inhibitor Sivelestat was from Cayman Chemical. Interleukin 8 (IL-8) 
was purchased from Peprotech (Rocky Hill, NJ). Antibodies against p38 MAPK phosphorylated 
at Thr180/Tyr182 (#9216) and p44/42 (Erk1/2) phosphorylated at Thr202/Tyr 204 (#9106). were 
from Cell Signaling.  
 
Isolation of human neutrophils and preparation of nitrogen cavitates  
Human neutrophils were isolated from whole blood obtained from healthy donors at the Scripps 
Research Institute. Two volumes of anti-coagulated blood (50mM EDTA) were layered over a 
double gradient formed by carefully layering one volume of Histopaque-1077 over one volume 
of Histopaque-1119 (both from Sigma-Aldrich). Blood cells were separated by centrifugation for 
30 min at 700 × g. The upper plasma layer and mononuclear cells at the plasma/Histopaque-1077 
interface were removed. The granulocytes were harvested from the Histopaque-1077/1119 
interface and washed twice with cold Hanks Balanced Salt Solution (HBSS, Thermo Fisher 
Scientific) by centrifugation for 10 min at 400 × g. Washed granulocytes were re-suspended at 
the desired concentration in serum-free (SF) DMEM supplemented with gentamicin (10 µg/mL). 
The purity of neutrophil fraction was verified with HEMO staining (Protocol) and was >95%. To 
open granule contents, isolated neutrophils placed into the cryogenic tubes at 1x107 cells/mL 
HBSS. Tubes were subjected to 3 freeze/thawing cycles in liquid nitrogen/warm water bath. 
After centrifugation at 4 min, 4000 × g, 4°C, the cell debris was removed and the nitrogen 
cavitates (NC) were kept at -20°C until use. 
 
NE activity assay 
To determine the NE activity in NC preparations, 30 µL of the sample were mixed with 350 nM 
of the elastase colorimetric substrate (Elastase substrate I, Calbiochem) in ammonium 
bicarbonate buffer (50 nM). The enzyme activity was assayed by a colorimetric detection at 405 
nm (SynergyMX, BioTek) using a calibration curve generated by titration of purified NE. 
Kinetic assays were run for 1h, allowing for the determination of Vmax values and calculation of 
NE activity using the Gen5 2.0 software. 
 
Tumor cells and culture conditions 
Human epidermoid HEp3 carcinoma cell line (Toolan, 1954) and an aggressive variant of  
human PC3 prostate carcinoma cell line possessing high disseminating potential, PC3-hi/diss 
(Conn et al., 2009), were used in this study. Murine carcinoma cells, MOC2, generated to study 
head and neck cancer in syngeneic mouse models ((Judd et al., 2012), were received from Dr. R. 
Upalluri of Washington School of Medicine (St. Louis, MO). Cells were cultured in Dulbecco’s 
modified Earle’s medium (DMEM), supplemented with glucose, sodium pyruvate, non-essential 
amino acids, gentamycin and 10% FBS (D10). For using in experiments, the cells were detached 




Cell proliferation and chemotactic cell migration 
HEp3 and PC3 cells were treated with purified NE at 100 nM for 2 or 6 hours, washed and 
suspended at 1x106 cells/mL SF-DMEM. For cell proliferation assays, washed cells were plated 
at 5x105 per well of 24-well cluster in D10. After 48 hours, cells were detached with trypsin-
EDTA and counted. For cell migration assays, washed cells were plated at 1x105 per insert of a 
6.5-µm Transwell with 8-µm pore size membrane. Cells were allowed to migrate towards 
chemoattractant in an outer chamber, 5% FBS or 100 nM of hepatocyte growth factor (HGF). 
Transmigrated cells were harvested after overnight incubation and counted. For NE inhibition 
experiments, the cells were first pretreated with NE inhibitors, 1PI and Sivelestat, or signaling 
inhibitors, Dasatinib and Wortmannin, at the indicated concentrations for 20 min, and then the 
cultures were treated with NE. 
 
Western blotting 
Sub-confluent layers of tumor cells plated the day before experiment were washed in SF-DMEM 
and treated with 100 nM purified NE for 20 min. For NE inhibition experiments, the cells were 
first pretreated with NE inhibitors, 1PI and Sivelestat or signaling inhibitors Dasatinib and 
Wortmannin at the indicated concentrations for 20 min, and then the cultures were treated with 
NE. Cells were lysed on ice with mRIPA buffer supplemented with the protease and phosphatase 
inhibitors (Sigma). Cell lysates were clarified by centrifugation and equal protein contents (20-
40 µg/lane) were separated by SDS-PAGE on 4-20% gels. The separated proteins were 
transferred to a PVDF membrane, blocked with 1% BSA, and incubated overnight with the 
mouse monoclonal antibody against Akt, phospho Akt, phospo p38, phosphor Erk1/2, -actin 
(all from Cell Signaling), C-terminal CD44 (Rb antibody from Boster), or N-terminal CD44 
mouse mAb 29-7 generated in our laboratory. The membranes were washed and incubated with 
the secondary antibodies conjugated with HRP (Cell Signaling). The bound secondary antibodies 
were visualized with West Pico substrate (Thermo Fisher Scientific).  
 
Animal studies 
All experiments involving animals were conducted in accordance with the Animal Protocol 
approved by TSRI Animal Care and Use Committee (IACUC). 
 
CAM angiogenesis model 
The effects of purified NE on tumor cell-induced angiogenesis were determined using a collagen 
onplant angiogenesis assay as described (Deryugina and Quigley, 2008a). Briefly, GFP-tagged 
HEp3 cells were incorporated at 1x106 cells per mL into 2.2 mg/mL neutralized native type I 
collagen (BD Biosciences) and 30 µL-droplets of the mixture were polymerized over grid 
meshes (3x4 mm) generating three-dimensional (3D) rafts (“onplants”) by incubating at 370C for 
20 min. Solidified onplants were grafted onto the chorioallantoic membrane (CAM) of 10 day-
old chick embryos incubated ex ovo (6 onplants/embryo). The onplants were treated daily with 
10 µL of 100 nM of NE or vehicle (PBS/1% DMSO). Within 68 h to 72 h, newly developed 
blood vessels that had grown into 3D collagen rafts were scored over the lower mesh using a 
stereoscope. The angiogenic index was calculated for each onplant as the ratio of number of 
grids having newly formed blood vessels over the total number of scored grids. To visualize the 
angiogenic blood vessels within collagen rafts, the onplant-bearing embryos were injected via 
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the allantoic vein with 100 ug of Rhodamine-conjugated Lens culinaris agglutinin (LCA; Vector 
laboratories) in 0.1 mL PBS. Portions of CAM with onplants were visualized for fluorescence in 
an Olympus microscope equipped with a digital video camera. To measure tumor cell 
intravasation, portions of CAM, 1-5 cm distal to collagen onplants, were harvested on day 5 after 
onplant grafting and processed for quantitative human-specific Alu-qPCR as described (Minder 
et al., 2015). 
 
CAM tumor model to study spontaneous metastasis 
To analyze the effects of purified NE, NC and intact neutrophils on intratumoral angiogenesis 
and tumor cell intravasation, CAM microtumor assays was employed as described (Deryugina, 
2016). Briefly, GFP-tagged HEp3 cells were suspended at 1x107 cells per mL within 2.2 mg/mL 
neutralized native type I collagen (BD Biosciences). Six 15 µL-droplets of cell-containing 
collagen mixtures were placed separately on the top of a CAM on 10 day-old chick embryos 
developing ex ovo (Deryugina and Quigley, 2008b). Developing tumors were treated daily by 
topical application of tested ingredients in PBS supplemented with 1% DMSO (vehicle). Purified 
NE was used at 100 nM, the NC was used at a concentration equivalent to 100 nM of NE 
activity, and α1PI was used at a final concentration of 300 nM. To assay the effect of intact 
neutrophils, freshly isolated neutrophils were injected on day 3 of microtumor development into 
the allantoic vein of chick embryos (2x106 neutrophils per embryo). After 5 days, 100 µg of 
Rhodamine-LCA in PBS was inoculated within 0.1 mL PBS in an allantoic vein to highlight 
chick embryo vasculature. Within 10-30 minutes, the portions of the CAM distal to tumors were 
excised and processed for Alu-qPCR to determine the number of intravasated human cells, after 
which the CAM microtumors were imaged using an Olympus IX51 microscope equipped with a 
QuantiFire XI digital microscope camera. Images were acquired at the original magnification of 
200X (20X objective and 10X eyepiece). In acquired images, intratumoral vasculature was 
analyzed using ImageJ for lumen size distribution. The lumen diameters were determined for 3-5 
areas within a tumor, 2-6 tumors per embryo, 3-5 embryos per group, allowing for statistically 
significant number of measurements.  
 
Pulmonary tumor cell arrest and lung retention in mice 
Lung retention experiments were conducted as described (Oncogene, 2012). WT and NE-KO 
mice (6-to-8-week-old) were injected through a lateral tail vein with 5x105 HEp3 cells or 1x106 
PC3 cells per mouse. Both sexes of mice were used throughout the study, although one the mice 
of one sex of similar age were used in an individual experiment. Tumor cell arrest in pulmonary 
vasculature and lung tissue retention of tumor cells was analyzed correspondingly after 30 
minutes or 12 hours following cell inoculations. Where indicated, the mice following cell 
injections were treated with Sivelestat at 1-1.5 mg/kg administered up to three times in 0.2 mL 
PBS/4%DMSO i.p. or i.v. during 12-hr-long duration of lung retention assays. Control. Mice 
were treated with vehicle (PBS/4% DMSO). Lung tissue was harvested and processed for 
human-specific Alu-qPCR to determine actual numbers of human cells using a standard curve as 
described (Conn et al., 2009; Deryugina and Kiosses, 2017; Minder et al., 2015).  
 
Mouse orthotopic model for spontaneous metastasis of head and neck cancer  
Mouse model to study mechanisms of spontaneous metastasis of head and neck cancer was 
performed as described (Deryugina et al., 2018). Herein, we employed an aggressive murine 
head and neck carcinoma cell line, MOC2, a syngeneic setting using genetically compatible 
C57BL/6 mice, WT and NE KO. Both sexes of mice were used throughout the study, although 
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one the mice of one sex of similar age were used in an individual experiment. MOC2 cells were 
inoculated into buccal lining of the upper lip at 1x106 per site (one site per mouse). After 12-14 
days, mice were sacrificed when primary tumors reached end point-size of ~0.5 cm in diameter. 
Tumors were excised and weighed. Lungs (the major organ for hematogenous dissemination of 
head and neck carcinomas in this model) were harvested and fixed for histological examination. 
Lung sections were stained with hematoxylin-eosin and digitally scanned. Areas in the lung 
tissue occupied by tumor cells were outlined and quantified using ImageJ software. 
 
Quantitative human-specific Alu-qPCR 
Dissemination of human tumor cells in CAM or mouse assays was measured by the 
quantification of human-specific Alu repeats in total DNA extracted from host tissue as described 
(Conn et al., 2009; Deryugina and Kiosses, 2017; Minder et al., 2015). The DNA was purified 
using the Puregene DNA purification kit from Qiagen. The Alu-qPCR was performed on 10 ng 
of genomic DNA in a Bio-Rad MyIQ LightCycler (Bio-Rad) using SYBR green (Life 
Technologies) as a binding dye. The Cq values were converted into number of human cells using 
a standard curve generated by spiking increasing numbers of human tumor cells (from 10 to 104 
cells) into a fixed number (106 cells) of chick embryo fibroblasts or murine B16 melanoma cells. 
 
Statistical analysis 
Data were analyzed using GraphPad Prism 7 (GraphPad Software, La Jolla, CA). In bar graphs 
the data are presented as mean ± SEM from either a representative experiment or several 
normalized pooled experiments. To normalize the data, the ratios of numerical values for each 
measurement over the mean of the control group of an individual experiment were calculated. 
The outliers were eliminated based on the Grubb’s test incorporated in GraphPad Software. The 
differences (P values) between data sets were analyzed with the unpaired two-tailed Student’s t-
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